3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Lymphoid
1
Conditions
Waldenstrom Macroglobulinemia
1
Multiple Myeloma
1
Interventions
zanubrutinib
2
ibrutinib
2
talquetamab
1
Thiotepa
1
Thalidomide
1
Sirolimus
1
Rituximab
1
Radiotherapy
1
Prednisone
1
Filgrastim
1
Everolimus
1
Cyclophosphamide
1
Bortezomib
1
Antilymphocyte Serum
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Waldenstrom Macroglobulinemia
×
talquetamab
×
Clear all
NCT07474961
2026-03-16
BLOOD-dose
Rigshospitalet, Denmark
Phase 4
Not yet recruiting
400 enrolled